Adipo Therapeutics
Adipo is developing a technology platform for localized Notch-inhibition, beginning with the transformation of subcutaneous fat. Its vision is to harness the power of brown fat to transform the treatment of people with metabolic diseases, starting with Type 2 diabetes mellitus (T2DM). The goal? Improving metabolic balance for millions of people living with T2DM.
Contact Name:
Karen F Wurster
Contact Email:
Website:
https://adipotherapeutics.com/
City, State – Congressional District:
Indianapolis,
IN
–
7
Technology:
Drug
Funding:
Diabetes, Digestive, and Kidney (NIDDK)
NIH Projects:
NIH RePorter for
Adipo Therapeutics
Sponsored Event(s):
BIO | 2020
